MARKET

AEMD

AEMD

Aethlon Medical
NASDAQ
3.040
-0.140
-4.40%
After Hours: 2.950 -0.09 -2.96% 19:54 08/12 EDT
OPEN
3.090
PREV CLOSE
3.180
HIGH
3.090
LOW
2.910
VOLUME
26.50K
TURNOVER
--
52 WEEK HIGH
137.00
52 WEEK LOW
2.625
MARKET CAP
1.98M
P/E (TTM)
-0.0573
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AEMD last week (0803-0807)?
Weekly Report · 2d ago
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026
Barchart · 08/05 07:01
Aethlon Medical trading halted, news pending
TipRanks · 08/03 23:50
Weekly Report: what happened at AEMD last week (0727-0731)?
Weekly Report · 08/03 10:18
Upcoming Stock Splits This Week (August 3 to August 7) – Stay Invested
TipRanks · 08/02 14:50
Aethlon Medical Announces Reverse Stock Split Implementation
TipRanks · 07/31 12:29
Weekly Report: what happened at AEMD last week (0720-0724)?
Weekly Report · 07/27 10:22
Weekly Report: what happened at AEMD last week (0713-0717)?
Weekly Report · 07/20 10:18
More
About AEMD
Aethlon Medical, Inc. is a clinical-stage medical device company. The Company is focused on advancing the Hemopurifier (HP), a clinical-stage immunotherapeutic device intended for applications in cancer, life-threatening viral infections, and organ transplantation and other areas of significant unmet needs. In pre-clinical studies, the Hemopurifier has exhibited the capacity to remove harmful extracellular vesicles (EVs) and enveloped viruses from biological fluids, utilizing its proprietary lectin-based mechanism. These extracellular vesicles have been implicated in disease processes such as immune suppression and metastasis in cancer as well as in the progression of severe life-threatening infectious diseases. The United States Food and Drug Administration (FDA) has designated the Hemopurifier as a Breakthrough Device for the treatment of individuals with advanced or metastatic cancer who are unresponsive to or intolerant of standard of care therapy.

Webull offers Aethlon Medical Inc stock information, including NASDAQ: AEMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AEMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AEMD stock methods without spending real money on the virtual paper trading platform.